Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenhuang Paste is a Traditional Chinese Medicine (TCM) topical formulation primarily used to alleviate chemotherapy-induced gastrointestinal toxicity (CIGT) in cancer patients, particularly those with breast cancer. The paste is typically applied to the Shenque point (umbilicus), a practice rooted in acupoint application therapy. Its primary ingredients, such as *Panax ginseng* (Renshen) and *Rheum palmatum* (Dahuang), are intended to regulate gastrointestinal motility, protect the intestinal mucosal barrier, and reduce symptoms like nausea, vomiting, and abdominal distension. It is being investigated by institutions such as Zhejiang Chinese Medical University as a supportive care intervention to improve the quality of life for patients undergoing emetogenic chemotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenhuang Paste.